Insights Across the
Access Ecosystem

The first 90 days after launch reveal whether access strategy is performing in clinical reality. Claims data alone shows utilization — not intent. Here’s why EMR-first evidence is becoming essential for decision-grade post-launch validation across pharmaceutical organizations.

Patient Support Programs were once designed as contained environments.Intake came in. Benefits were verified. Prior authorizations were tracked. Financial support was coordinated. Reports were generated.Everything lived inside the hub.But as more manufacturers explore insourced and hybrid hub models, the infrastructure behind patient services is becoming far more complex.In today’s environment, access depends on connection.Prescribing systems evolve. Specialty pharmacy platfo

“Standard of care” sounds straightforward — but treatment patterns vary widely across payers, geographies, and health systems. When comparator assumptions don’t reflect real-world practice, value arguments can lose credibility. Here’s why comparator strategy deserves closer scrutiny.

Winning coverage doesn’t guarantee adoption. Access friction, from benefit design to provider workflow, can quietly undermine uptake after launch. Here’s how leading teams map and address breakdown points before performance drifts.

Free goods alone can’t sustain modern Patient Assistance Programs. Learn how tech-enabled, compliant PAP design supports scalability, transparency, and long-term access.

Field Reimbursement Managers need more than reports—they need real-time visibility. Learn how modern PSP design and HealthPACER® empower FRMs with actionable insight that drives smarter access strategy.

Winning coverage doesn’t guarantee real-world uptake. Many access strategies break after launch, when early signals fail to predict how products perform in practice. Here’s why coverage alone isn’t enough — and where teams should be looking next.

Contracting rarely follows the original script. As payer assumptions shift mid-negotiation, access teams need real-time insight to adapt quickly and protect leverage. Here’s how leading teams stay ahead.

Many patient support programs perform well at launch but struggle as volume grows. This post explores why scalability requires intentional design—covering capacity planning, automation thresholds, and workflow elasticity as core principles for long-term PSP success.

As contracting season ramps up, payers are testing subscription pilots, outcomes triggers, and hybrid models alongside traditional rebates. Here’s what’s emerging — and how manufacturers should prepare.

“Visibility” means something different depending on who’s looking. Brands, FRMs, patient services teams, and compliance leaders all rely on visibility—but not the same kind. This post explores why patient support programs must deliver role-specific views without duplicative reporting to truly support access, accountability, and performance.

Insight alone no longer drives access success. Learn how leading organizations activate insight across HEOR, Medical, and Commercial to move faster, stay aligned, and support real-world decision-making.

Fragmented intake slows access, increases rework, and strains patient services teams. Learn how unified intake and case orchestration through HealthPACER® improve continuity and reduce delays.

Speed alone doesn’t fix access delays. Learn why reducing rework through better PSP design has a greater impact on time-to-therapy and provider trust.

As payer expectations, policy, and pricing dynamics continue to shift, static access plans are falling short. Learn how scenario thinking and simulation help market access teams prepare for uncertainty, and lead with confidence.

2026 is here, and PSP expectations are higher. See how eMAX is advancing interoperability, caregiver engagement, FRM visibility, and outcomes-linked analytics.

Payers are raising the bar on evidence in 2026, demanding endpoints, real-world outcomes, comparators, and credibility that support real coverage decisions. This blog explores what payers will expect in the year ahead—and how HEOR and access teams can reset their evidence strategies to stay ahead.

A year-in-review look at five access trends that shaped 2025 — from PAP sustainability to benefit crossover friction — and how PSP models are evolving for 2026.

Quarterly planning cycles can’t keep pace with the rapid shifts expected in 2026. Learn why static launch plans are no longer enough—and how continuous payer insight, real-time modeling, and cross-functional activation are becoming essential for modern market access strategy.

Payers are signaling exactly how they’ll evaluate price, value, evidence, and contracting in 2026. Based on real-time MAVA® panel insights, this blog outlines the expectations shaping next year’s access environment—and how manufacturers can prepare with clearer evidence, scenario-based contracting, and continuous payer engagement.